HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oxybutynin in detrusor overactivity.

Abstract
Oxybutynin has been used for the management of detrusor overactivity for over 30 years and has withstood medical scrutiny and the test of time throughout the world. Although several agents in the class of bladder relaxants have only recently been studied, oxybutynin's effectiveness in reducing urinary frequency and urge urinary incontinence is unquestioned in the medical literature. Oxybutynin is extremely safe and effective in almost every population including children, the elderly, and those who have neurogenic bladder. With more preparations available and more dosing flexibility than any other anticholinergic medication on the market, oxybutynin remains the "gold standard" for first-line therapy for patients who have detrusor overactivity.
AuthorsAnanias Diokno, Michael Ingber
JournalThe Urologic clinics of North America (Urol Clin North Am) Vol. 33 Issue 4 Pg. 439-45, vii (Nov 2006) ISSN: 0094-0143 [Print] United States
PMID17011379 (Publication Type: Journal Article, Review)
Chemical References
  • Mandelic Acids
  • Muscarinic Antagonists
  • oxybutynin
Topics
  • Humans
  • Mandelic Acids (therapeutic use)
  • Muscarinic Antagonists (therapeutic use)
  • Urinary Bladder, Overactive (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: